| Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. | |
| | |
MedLine Citation:
|
PMID: 12491515 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The age specific breast cancer incidence rate for African-American women under age 35 is more than twice the rate for white women of similar age, and the mortality rate is more than three times higher. To determine factors that may explain racial/ethnic variation in outcomes among young women diagnosed with breast cancer, the authors examined the clinical presentation, treatment, and survival of African-American, Hispanic, and white women under age 35 years. METHODS: Surveillance, Epidemiology, and End Results (SEER) Program data for 1990-1998 and SEER Patterns of Care data for 1990, 1991, and 1995 were used for this analysis. Multivariate logistic regression analyses were performed to examine factors associated with the receipt of selected breast cancer treatments. Kaplan-Meier survival analyses and Cox proportional hazards regression analyses were used to examine 5-year overall survival and disease-specific survival. RESULTS: The authors found racial/ethnic variation in clinical presentation, treatment, and survival. Both African-American and Hispanic women presented with higher disease stage and a higher prevalence of adverse prognostic indicators compared to white women. African-American and Hispanic women received cancer-directed surgery and radiation less frequently after undergoing breast-conserving surgery. Racial/ethnic differences in clinical presentation and treatment were associated with poorer overall survival in unadjusted analyses. African-American and Hispanic women also had poorer overall survival after controlling for clinical and demographic characteristics and type of treatment. CONCLUSIONS: Future research studies should further examine the factors that influence racial/ethnic differences in incidence, clinical presentation, and treatment differentials among young women diagnosed with breast cancer. A better understanding of these factors will facilitate the development of strategies to help eliminate this health disparity. |
| | |
Authors:
|
Vickie L Shavers; Linda C Harlan; Jennifer L Stevens |
Related Documents
:
|
10404085 - Effect of c-erbb(2) and estrogen receptor status on survival of women with primary brea... 17453365 - Differences in outcome for positive margins in a large cohort of breast cancer patients... 9469335 - Survey of breast cancer patients concerning their knowledge and expectations of adjuvan... 20554945 - Factor v leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen... 11903115 - Familial and environmental risk factors in parkinson's disease: a case-control study in... 10080665 - A first survey of organized cervical cancer screening programs in italy. gisci working ... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Cancer Volume: 97 ISSN: 0008-543X ISO Abbreviation: Cancer Publication Date: 2003 Jan |
Date Detail:
|
Created Date: 2002-12-19 Completed Date: 2003-01-24 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0374236 Medline TA: Cancer Country: United States |
Other Details:
|
Languages: eng Pagination: 134-47 Citation Subset: AIM; IM |
Copyright Information:
|
Published 2003 by the American Cancer Society. |
Affiliation:
|
Applied Research Program, Health Service and Economics Branch, Division of Cancer Control and Population Science, National Cancer Institute, 6130 Executive Boulevard, MSC 7344, EPN Room 4005, Bethesda, MD 20892-7344, USA. shaversv@mail.nih.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult African Continental Ancestry Group* Breast Neoplasms / ethnology*, pathology, therapy Demography European Continental Ancestry Group* Female Hispanic Americans* Humans Incidence Mastectomy, Segmental Neoplasm Staging Prognosis SEER Program Survival Rate United States / epidemiology |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurr...
Next Document: A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refract...